Suppr超能文献

微生物之战:体内的较量——肠道微生物群与多发性硬化症

Game of microbes: the battle within - gut microbiota and multiple sclerosis.

作者信息

Turner Ti-Ara, Lehman Peter, Ghimire Sudeep, Shahi Shailesh K, Mangalam Ashutosh

机构信息

Interdisciplinary Graduate Program in Immunology, University of Iowa, Iowa City, IA, USA.

Iowa City VA Health Care System, Iowa City, IA, USA.

出版信息

Gut Microbes. 2024 Jan-Dec;16(1):2387794. doi: 10.1080/19490976.2024.2387794. Epub 2024 Aug 8.

Abstract

Multiple sclerosis (MS) is a chronic and progressive autoimmune disease of the central nervous system (CNS), with both genetic and environmental factors contributing to the pathobiology of the disease. While human leukocyte antigen (HLA) genes have emerged as the strongest genetic factor, consensus on environmental risk factors are lacking. Recently, trillions of microbes residing in our gut (microbiome) have emerged as a potential environmental factor linked with the pathobiology of MS as PwMS show gut microbial dysbiosis (altered gut microbiome). Thus, there has been a strong emphasis on understanding the factors (host and environmental) regulating the composition of the gut microbiota and the mechanism(s) through which gut microbes contribute to MS disease, especially through immune system modulation. A better understanding of these interactions will help harness the enormous potential of the gut microbiota as a therapeutic approach to treating MS.

摘要

多发性硬化症(MS)是一种中枢神经系统(CNS)的慢性进行性自身免疫性疾病,遗传和环境因素均对该疾病的病理生物学产生影响。虽然人类白细胞抗原(HLA)基因已成为最强的遗传因素,但对于环境危险因素尚未达成共识。最近,存在于我们肠道中的数万亿微生物(微生物组)已成为与MS病理生物学相关的潜在环境因素,因为MS患者表现出肠道微生物群失调(肠道微生物组改变)。因此,人们一直非常重视了解调节肠道微生物群组成的因素(宿主和环境)以及肠道微生物促成MS疾病的机制,特别是通过免疫系统调节的机制。更好地理解这些相互作用将有助于利用肠道微生物群的巨大潜力,将其作为治疗MS的一种治疗方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/602a/11313001/d47e46cd9474/KGMI_A_2387794_F0001_OC.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验